foxo4-dri mechanism of action The disordered p53 transactivation domain is the target FOXO4 and the senolytic compound Development of a novel senolytic
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI Results: What to Expect (2026) FOXO4 DRI 10mg Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell
Pay in 4 interest-free payments of $7.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



